Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Chang

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Clinical Journal of Pain|April 9, 2005
The time to onset and overall analgesic efficacy of rofecoxib 50 mg: a meta-analysis of 13 randomized clinical trialsPaul J Desjardins, Donald R Mehlisch, David J Chang, et al.
Epilepsia|March 7, 2002
Comparison of statistical parametric mapping and SPECT difference imaging in patients with temporal lobe epilepsyDavid J Chang, I George Zubal, Chris Gottschalk, et al.
Lancet (London, England)|July 19, 2008
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialPaul Emery, Ferdinand C Breedveld, Stephen Hall, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|July 28, 2007
A double-blind randomized controlled trial of rofecoxib and multidose oxycodone/acetaminophen in dental impaction painPaul J Desjardins, Peter M Black, Stephen E Daniels, et al.
Clinical and Experimental Rheumatology|February 25, 2011
Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practiceRobert J Moots, Boulos Haraoui, Marco Matucci-Cerinic, et al.
Blood|May 27, 2026
CD19 CAR T Therapy Is Feasible in Patients with Pemphigus Vulgaris Treated Without Lymphodepletion in the RESET-PV TrialDaniel Nunez, Jason Stadanlick, Thomas Furmanak, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Clinical Journal of Pain|April 9, 2005
The time to onset and overall analgesic efficacy of rofecoxib 50 mg: a meta-analysis of 13 randomized clinical trialsPaul J Desjardins, Donald R Mehlisch, David J Chang, et al.
Epilepsia|March 7, 2002
Comparison of statistical parametric mapping and SPECT difference imaging in patients with temporal lobe epilepsyDavid J Chang, I George Zubal, Chris Gottschalk, et al.
Lancet (London, England)|July 19, 2008
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialPaul Emery, Ferdinand C Breedveld, Stephen Hall, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|July 28, 2007
A double-blind randomized controlled trial of rofecoxib and multidose oxycodone/acetaminophen in dental impaction painPaul J Desjardins, Peter M Black, Stephen E Daniels, et al.
Clinical and Experimental Rheumatology|February 25, 2011
Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practiceRobert J Moots, Boulos Haraoui, Marco Matucci-Cerinic, et al.
Blood|May 27, 2026
CD19 CAR T Therapy Is Feasible in Patients with Pemphigus Vulgaris Treated Without Lymphodepletion in the RESET-PV TrialDaniel Nunez, Jason Stadanlick, Thomas Furmanak, et al.
Pageof 3